Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
2013
Micro-RNA: new players in HIV-pathogenesis, diagnosis, prognosis and antiviral therapy
HIV Incidence in Asia: A Review of Available Data and Assessment of the Epidemic
Liver Toxicity in HIV-Infected Patients Receiving Novel Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors Etravirine and Rilpivirine
Lipid Metabolism and Cardiovascular Risk in HIV Infection: New Perspectives and the Role of Nevirapine
Effects of Political Conflict-Induced Treatment Interruptions on HIV Drug Resistance
Vaccinating HIV Patients: Focus on Human Papillomavirus and Herpes Zoster Vaccines
Late Diagnosis of HIV Infection among Prisoners
Current Status of HIV-1 Diversity and Drug Resistance Monitoring In the Former USSR
The Changing Epidemiology of Liver Disease in HIV Patients
Clinical Perspective on Drug‑Drug Interactions with the Non-nucleoside Reverse Transcriptase Inhibitor Rilpivirine